BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2578530)

  • 1. Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes.
    Reichert U; Jacques Y; Grangeret M; Schmidt R
    J Invest Dermatol; 1985 Feb; 84(2):130-4. PubMed ID: 2578530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of secondary radicals in the mode of action of anthralin.
    Lambelet P; Ducret F; Löliger J; Maignan J; Reichert U; Shroot B
    Free Radic Biol Med; 1990; 9(3):183-90. PubMed ID: 2177025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of DNA replication and repair by anthralin or danthron in cultured human cells.
    Clark JM; Hanawalt PC
    J Invest Dermatol; 1982 Jul; 79(1):18-22. PubMed ID: 7086172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DNA replication and repair cultured humans cells by anthralin or danthron.
    Clark JM; Hanawalt PC
    Br J Dermatol; 1981 Aug; 105 Suppl 20():49-50. PubMed ID: 7284265
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of anthralin and analogues on growth and [3H] thymidine incorporation in human skin fibroblasts.
    Jacques Y; Reichert U
    Br J Dermatol; 1981 Aug; 105 Suppl 20():45-8. PubMed ID: 7284264
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivation of mouse epidermal 12-lipoxygenase by anthralin--implications for the role of oxygen radicals.
    Müller K; Gawlik I
    Biochem Pharmacol; 1996 May; 51(9):1173-9. PubMed ID: 8645340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils.
    Schröder JM; Kosfeld U; Christophers E
    J Invest Dermatol; 1985 Jul; 85(1):30-4. PubMed ID: 2989375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro.
    Bedord CJ; Young JM; Wagner BM
    J Invest Dermatol; 1983 Dec; 81(6):566-71. PubMed ID: 6417248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of 3H-thymidine into DNA: inhibition by dithranol and its di- and triacetate.
    Plumier E; Wappes B; Wiegrebe W
    Arch Dermatol Res; 1984; 276(6):406-8. PubMed ID: 6517613
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of anthralin (dithranol) on mitochondria.
    Morlière P; Dubertret L; Sa e Melo T; Salet C; Fosse M; Santus R
    Br J Dermatol; 1985 May; 112(5):509-15. PubMed ID: 4005152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional analysis of the interaction of anthralin and its metabolites anthraquinone and anthralin dimer with the inner mitochondrial membrane.
    Fuchs J; Milbradt R; Zimmer G
    Arch Dermatol Res; 1990; 282(1):47-55. PubMed ID: 2317083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relationship of new anthralin derivatives assayed for growth inhibition and cytotoxicity in human keratinocyte cultures.
    Bonnekoh B; Tanzer H; Seidel M; Geisel J; Merk HF; Mahrle G; Wiegrebe W
    Arch Pharm (Weinheim); 1991 Nov; 324(11):899-906. PubMed ID: 1804068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A microspectrofluorometric study of the effect of anthralin, an antipsoriatic drug, on cellular structures and metabolism.
    Kohen E; Kohen C; Morliere P; Santus R; Reyftmann JP; Dubertret L; Hirschberg JG; Coulomb B
    Cell Biochem Funct; 1986 Jul; 4(3):157-68. PubMed ID: 3731395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anthralin and its derivatives on epidermal cell kinetics.
    Fisher LB; Maibach HI
    J Invest Dermatol; 1975 May; 64(5):338-41. PubMed ID: 1141709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition.
    Cavey D; Caron JC; Shroot B
    J Pharm Sci; 1982 Sep; 71(9):980-3. PubMed ID: 7131282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antipsoriatic compound anthralin influences bioenergetic parameters and redox properties of energy transducing membranes.
    Fuchs J; Nitschmann WH; Packer L
    J Invest Dermatol; 1990 Jan; 94(1):71-6. PubMed ID: 2104916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
    Schröder JM
    J Invest Dermatol; 1986 Nov; 87(5):624-9. PubMed ID: 3021863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cornified envelope formation by anthralin, simple analogues, and related anthracenones.
    Müller K; Reindl H
    Arch Pharm (Weinheim); 2001 Mar; 334(3):86-92. PubMed ID: 11315339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of epidermal growth factor receptors by dithranol.
    Kemény L; Michel G; Arenberger P; Ruzicka T
    Acta Derm Venereol; 1993 Feb; 73(1):37-40. PubMed ID: 8095749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
    Van Duuren BL; Segal A; Tseng SS; Rusch GM; Loewengart G; Maté U; Roth D; Smith A; Melchionne S; Seidman I
    J Med Chem; 1978 Jan; 21(1):26-31. PubMed ID: 619147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.